ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy vaccine art science publishing

Arts And Sciences Academy 'Revels In Independence'
Steven Benowitz | Jul 10, 1994 | 7 min read
"Certainly the arms control, federal government, and academic communities know about us, but our name recognition with the public is low," says academy executive officer Joel Orlen. "When I mention where I work, most people confuse the organization with the American Academy of Motion Picture Arts and Sciences, the group that gives out the Academy Awards." The academy recognizes accomplishment in mathematics, the physical and biolog
Arts And Sciences Academy 'Revels In Independence'
Steven Benowitz | Jul 10, 1994 | 7 min read
"Certainly the arms control, federal government, and academic communities know about us, but our name recognition with the public is low," says academy executive officer Joel Orlen. "When I mention where I work, most people confuse the organization with the American Academy of Motion Picture Arts and Sciences, the group that gives out the Academy Awards." The academy recognizes accomplishment in mathematics, the physical and biolog
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Week in Review: January 30–February 3
Joshua A. Krisch | Feb 2, 2017 | 3 min read
March for science debate; an RNA vaccine for Zika; responses to Trump’s immigration order; native habitat restoration; views from local March for Science organizers; artificial cells and the Turing test
The Year in Pathogens
Molly Sharlach | Dec 28, 2014 | 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
Vaccines: Victims of Their Own Success?
Ricki Lewis | Jul 18, 2004 | 10+ min read
Perhaps in no area is the divide between the developed and developing worlds as striking as it is for vaccines: While healthcare consumers in economically advantaged nations worry about risk, in developing nations compelling need forces a focus on potential benefit. "People in the United States want a quick solution, not prevention, so they prefer drugs to vaccines. Elsewhere, people are afraid of drugs and side effects, and prefer vaccines," says Shan Lu, a primary-care physician who has worked
EXCLUSIVE
Stethoscope on top of form and clipboard
Robert Malone Targets Physician Who Alerted Medical Board to Misinformation
Catherine Offord | Feb 19, 2022 | 8 min read
A Hawaii hospital worker who reported the controversial scientist to the Maryland Board of Physicians was subjected to harassment and a retaliatory complaint after Malone made his name and location public.
An AIDS Vaccine by 2007? Not Likely, Say Participants
Myrna Watanabe | Jun 7, 1998 | 10 min read
May 18 marked the one-year anniversary of President Bill Clinton's pledge--some say more politically motivated than realistic--that there will be an AIDS vaccine by the year 2007. READY FOR PHASE III: Donald Francis of VaxGen is ready for Phase III trials of its AIDS vaccine to begin. The field of AIDS vaccine research has been and remains acrimonious. The basic researchers who insist on proof of immune response prior to large clinical trials disagree with the vaccine researchers whose experi
The Globalization of Science: Reality Confronts an Ideal
Richard Gallagher | Mar 14, 2004 | 2 min read
To survive in the world we have transformed, we must learn to think in a new way. As never before, the future of each depends on the good of all.1- Statement by 100 Nobel laureatesGlobalization has multiple personas; one of the more benevolent extols a world of mutual cooperation and interdependence. In recent weeks, much ink has been spilled over the contribution that science and technology can make to this idyll of global security and prosperity. Most notable of these was the debut of the Inte
The Threat of Biological Weapons Must Be Addressed
Joshua Lederberg | Mar 14, 1999 | 6 min read
Editor's Note: Joshua Lederberg, chairman of The Scientist's Editorial Advisory Board, edited the book Biological Weapons: Limiting the Threat, to be published this spring (May 1999) by The MIT Press. The following article, adapted from the book's epilogue, is printed with permission of The MIT Press. As the works for Biological Weapons: Limiting the Threat were being assembled, our policy perspectives were informed by new happenings and governmental reactions. Saddam Hussein renewed his h

Run a Search

ADVERTISEMENT